SG76623A1 - Spiro [piperidine-4, 1'-pyrrolo[3,4-c]pyrrole] - Google Patents

Spiro [piperidine-4, 1'-pyrrolo[3,4-c]pyrrole]

Info

Publication number
SG76623A1
SG76623A1 SG1999002779A SG1999002779A SG76623A1 SG 76623 A1 SG76623 A1 SG 76623A1 SG 1999002779 A SG1999002779 A SG 1999002779A SG 1999002779 A SG1999002779 A SG 1999002779A SG 76623 A1 SG76623 A1 SG 76623A1
Authority
SG
Singapore
Prior art keywords
pyrrolo
spiro
pyrrole
piperidine
Prior art date
Application number
SG1999002779A
Other languages
English (en)
Inventor
Geo Adam
Frank Dautzenberg
Sabine Kolczewski
Stephan Rover
Jurgen Wichmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG76623A1 publication Critical patent/SG76623A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG1999002779A 1998-06-12 1999-06-09 Spiro [piperidine-4, 1'-pyrrolo[3,4-c]pyrrole] SG76623A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98110803 1998-06-12
EP98124119 1998-12-18

Publications (1)

Publication Number Publication Date
SG76623A1 true SG76623A1 (en) 2000-11-21

Family

ID=26149342

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1999002779A SG76623A1 (en) 1998-06-12 1999-06-09 Spiro [piperidine-4, 1'-pyrrolo[3,4-c]pyrrole]

Country Status (27)

Country Link
US (1) US6075034A (no)
EP (1) EP0963987B1 (no)
JP (1) JP3308507B2 (no)
KR (1) KR100346607B1 (no)
AR (1) AR018650A1 (no)
AT (1) ATE222908T1 (no)
AU (1) AU749995B2 (no)
BR (1) BR9902245A (no)
CA (1) CA2274204C (no)
CO (1) CO5060459A1 (no)
DE (1) DE69902606T2 (no)
DK (1) DK0963987T3 (no)
ES (1) ES2181336T3 (no)
HR (1) HRP990189A2 (no)
HU (1) HUP9901909A3 (no)
ID (1) ID23283A (no)
IL (1) IL130376A0 (no)
MA (1) MA26643A1 (no)
NO (1) NO312069B1 (no)
NZ (1) NZ336186A (no)
PE (1) PE20000549A1 (no)
PL (1) PL333694A1 (no)
PT (1) PT963987E (no)
SG (1) SG76623A1 (no)
TR (1) TR199901304A3 (no)
TW (1) TW523516B (no)
YU (1) YU26599A (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1342717A4 (en) 2000-11-15 2005-02-16 Banyu Pharma Co Ltd benzimidazole derivatives
US20030040479A1 (en) * 2001-07-02 2003-02-27 Omeros Corporation Rotational intrathecal analgesia method and device
JP2005502619A (ja) * 2001-07-02 2005-01-27 オメロス コーポレイション オピオイドレセプター様レセプター１アゴニストと交替でオピオイドレセプターアゴニストを投与することを含む、痛覚脱失を生成するための方法
JP2005289816A (ja) 2002-05-14 2005-10-20 Banyu Pharmaceut Co Ltd ベンズイミダゾール誘導体
ZA200510329B (en) * 2003-05-23 2007-04-25 Zealand Pharma As Triaza-spiro compounds as nociceptin analogues and uses thereof
US20050228023A1 (en) * 2003-12-19 2005-10-13 Sri International Agonist and antagonist ligands of the nociceptin receptor
JP4446978B2 (ja) * 2006-04-28 2010-04-07 トヨタ自動車株式会社 車両用駆動力制御装置
BRPI0808025A2 (pt) * 2007-03-01 2014-06-24 Mitsubishi Tanabe Pharma Corp Composto de benzimidazol e uso farmacêutico do mesmo
KR101561666B1 (ko) 2014-08-12 2015-10-20 최인석 골프 퍼팅 교정장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
CA2226058C (en) * 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives

Also Published As

Publication number Publication date
IL130376A0 (en) 2000-06-01
KR100346607B1 (ko) 2002-08-07
TW523516B (en) 2003-03-11
PE20000549A1 (es) 2000-07-24
EP0963987A3 (en) 2001-01-17
AU3500399A (en) 1999-12-23
HUP9901909A3 (en) 2001-11-28
ID23283A (id) 2000-04-05
DK0963987T3 (da) 2002-12-30
DE69902606D1 (de) 2002-10-02
NO992872L (no) 1999-12-13
TR199901304A2 (xx) 2000-01-21
CA2274204A1 (en) 1999-12-12
TR199901304A3 (tr) 2000-01-21
PL333694A1 (en) 1999-12-20
YU26599A (sh) 2002-09-19
AU749995B2 (en) 2002-07-04
PT963987E (pt) 2003-01-31
HU9901909D0 (en) 1999-08-30
ATE222908T1 (de) 2002-09-15
NO992872D0 (no) 1999-06-11
EP0963987B1 (en) 2002-08-28
NZ336186A (en) 2000-10-27
KR20000006079A (ko) 2000-01-25
DE69902606T2 (de) 2003-04-24
HUP9901909A2 (hu) 2000-04-28
CO5060459A1 (es) 2001-07-30
AR018650A1 (es) 2001-11-28
BR9902245A (pt) 2000-03-21
MA26643A1 (fr) 2004-12-20
JP3308507B2 (ja) 2002-07-29
HRP990189A2 (en) 2000-02-29
JP2000053680A (ja) 2000-02-22
CA2274204C (en) 2009-09-15
US6075034A (en) 2000-06-13
ES2181336T3 (es) 2003-02-16
EP0963987A2 (en) 1999-12-15
NO312069B1 (no) 2002-03-11

Similar Documents

Publication Publication Date Title
DE59409351D1 (de) Pyrrolo[3,4-c]pyrrole
HRP970346A2 (en) Phenylamino-substituted tricyclic derivatives
AP9901583A0 (en) Pyrrolo[2,3-d] pirimidine compounds
IL125589A0 (en) Pyrimidin-4-one derivatives as pesticides
HUP9900575A3 (en) Pyrazolopyrimidines as crf receptor antagonists
SG54341A1 (en) Tricyclic 5,6-dihydro-9h-pyrazola[3,4-c] 1,2,4-triazolo[4,3-alpha] pyridines
SG79259A1 (en) Diaza-spiro[3,5]nonane deravatives
SG76623A1 (en) Spiro [piperidine-4, 1'-pyrrolo[3,4-c]pyrrole]
ZA993853B (en) Spiro[piperidine-4,1'-pyrolo(3,4-C)pyrrole].
ZA972829B (en) Novel pyrimido [1,2-a]indoles.
IL135982A0 (en) Fungicidal combinations comprising thieno[2,3-d]pyrimidin-4-one
IL124453A0 (en) 2,7-substituted octahydro-pyrrolo [1,2-A]pyrazine derivatives
IL142630A0 (en) FUNGICIDAL COMBINATIONS COMPRISING THIENO [2,3-d] PYRIMIDIN-4-ONE
HUP0003692A3 (en) Pyrimido[4,5-b]indolyl-alkanecarboxamide derivatives
ZA972984B (en) Spiro[cyclopent[b]indole-piperidines.
GB2316072B (en) Pyrrolo[3,2-c]quinoline derivatives
EP0424315A3 (en) Tetracyclic pyrrole lactam derivatives
AU1399199A (en) Immunosuppressant tetracyclic triterpenes
IL113673A0 (en) 5,6-dihydro-4h- thieno [3,4-c] pyrrole derivatives, their preparation and their therapeutic application
ZA964649B (en) Tricyclic 5,6-dihydro-9H-pyrazolo[3,4c]-1,2,4-triazolo[4,3a]pyridines.
GB9807363D0 (en) Immunosuppressant tetracyclic triterpenes
GB9602519D0 (en) Cyclisation
SI1038525T1 (en) Stabilized composition of tetrahydropyrrolo (1,2-a) pyrazine-4-spiro-3'-pyrrolidine
ZA988863B (en) Vehicle acquisition
AU129519S (en) Padlock body